abstract |
This invention provides compounds, methods, immunoassays, and kits relating to active, metabolically sensitive ('met-sensitive') moieties of anti-HIV therapeutics, such as HIV protease inhibitors (PI) and HIV non-nucleoside reverse transcriptase inhibitors (NNRTI). |